Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer
Authors
Keywords
-
Journal
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-27
DOI
10.1111/jog.14391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Saved by the evidence: Hyperthermic intraperitoneal chemotherapy still has a role to play in ovarian cancer
- (2019) Vincent Lavoué et al. EJSO
- ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†
- (2019) N Colombo et al. ANNALS OF ONCOLOGY
- Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial
- (2019) Simone N. Koole et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
- (2019) Joan L. Walker et al. JOURNAL OF CLINICAL ONCOLOGY
- Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?
- (2019) Ignace Vergote et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma
- (2018) Hideaki Tsuyoshi et al. CANCER SCIENCE
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) Willemien J. van Driel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
- (2018) Andrea Jewell et al. Cancers
- Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis
- (2018) Yizi Wang et al. EJSO
- Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer
- (2018) Ida Paris et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
- (2017) Beatrice Seddon et al. LANCET ONCOLOGY
- 18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma
- (2017) Makoto Yamamoto et al. Oncotarget
- Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer
- (2016) S. Gouy et al. GYNECOLOGIC ONCOLOGY
- Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results
- (2015) Paul Sugarbaker et al. ANNALS OF SURGICAL ONCOLOGY
- Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
- (2014) J. Spiliotis et al. ANNALS OF SURGICAL ONCOLOGY
- HIPEC ROC I: A phase i study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer
- (2014) Oliver Zivanovic et al. INTERNATIONAL JOURNAL OF CANCER
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent high-grade uterine sarcoma with peritoneal dissemination
- (2013) William A. Jimenez et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients
- (2012) Lana Bijelic et al. Gastroenterology Research and Practice
- Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis
- (2011) P.H. Sugarbaker et al. EJSO
- Systematic Review on the Efficacy of Multimodal Treatment of Sarcomatosis with Cytoreduction and Intraperitoneal Chemotherapy
- (2010) Gitonga Munene et al. ANNALS OF SURGICAL ONCOLOGY
- Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?
- (2010) Dario Baratti et al. ANNALS OF SURGICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started